Armata Pharmaceuticals, Inc. Common Stock vs. Kymera Therapeutics, Inc. Common Stock
ARMP
Armata Pharmaceuticals, Inc. Common Stock
$4.68 +2.63%
VS KYMRKymera Therapeutics, Inc. Common Stock
$124.28 +2.39%
Kymera Therapeutics, Inc. Common Stock (KYMR) comes out ahead, leading on 2 of 2 compared factors.
Size & Scale
| ARMP | KYMR | |
|---|---|---|
| Market Cap | $166.58 million | $10.10 billion |
| Revenue (TTM) | — | $105.00 million |
| Net Income (TTM) | — | $-299,601,000 |
KYMR leads on 1 of 1 size & scale factors.
Valuation
| ARMP | KYMR | |
|---|---|---|
| Price / Book | — | 6.69 |
| Price / Sales | — | 96.15 |
ARMP and KYMR split the valuation factors evenly.
Profitability
| ARMP | KYMR | |
|---|---|---|
| Net Margin | — | -285.34% |
| Return on Equity | — | -19.85% |
ARMP and KYMR split the profitability factors evenly.
Risk & Sentiment
| ARMP | KYMR | |
|---|---|---|
| Short Interest | 0.37% | 0.24% |
KYMR leads on 1 of 1 risk & sentiment factors.
Dig deeper: ARMP overview, ARMP financials, KYMR overview, KYMR financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.